Utilizing nanotechnology to recuperate sorafenib for lung cancer treatment: challenges and future perspective

Ther Deliv. 2020 Apr;11(4):213-215. doi: 10.4155/tde-2019-0098. Epub 2020 Jan 15.
No abstract available

Keywords: formulation approaches; nanocarriers; non-small-cell lung cancer (NSCLC); pulmonary delivery; sorafenib; tyrosine-kinase inhibitor.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Humans
  • Lung Neoplasms / drug therapy*
  • Nanotechnology / trends*
  • Sorafenib / therapeutic use*

Substances

  • Antineoplastic Agents
  • Sorafenib